Alterity Therapeutics (ATHE) Total Liabilities (2009 - 2025)

Alterity Therapeutics (ATHE) has reported Total Liabilities for 17 consecutive years, with $1.9 million the latest figure, recorded in Q4 2025.

• Quarterly Total Liabilities fell 3.98% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 3.98% YoY) and the FY2025 annual result came in at $2.6 million, down 33.22% from the prior year.
• Total Liabilities retreated to $1.9 million in Q4 2025 per ATHE's latest filing, from $2.6 million in the prior quarter.
• Over the last five years, Total Liabilities for ATHE reached as high as $4.2 million in Q2 2022 and fell as low as -$6.3 million in Q2 2024.
• A 5-year average of $1.6 million and a median of $2.4 million in 2021 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2024 — Total Liabilities tumbled 13981.18% — and 2025, when it surged 140.92%.
• Year by year, Total Liabilities stood at $2.7 million in 2021, then surged by 38.85% to $3.7 million in 2022, then fell by 13.45% to $3.2 million in 2023, then tumbled by 39.58% to $1.9 million in 2024, then retreated by 3.98% to $1.9 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.9 million, $2.6 million, and $1.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.